BEAM•benzinga•
B of A Securities Upgrades Beam Therapeutics to Buy, Maintains Price Target to $42
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 28, 2025 by benzinga